Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

Aversi Clinic50 enrolled

Overview

The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation

Study Type

OBSERVATIONAL

Enrollment

Conditions

Patient Participation

Interventions

perindopril-bisoprololDRUG

outpatients with permanent atrial fibrillation and with preserved ejection fraction

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria:permanent atrial fibrillation with normal EF - Exclusion Criteria:AF with decreased EF \-

Locations (2)

Aversi Clinic

Tbilisi, Georgia

Aversi Clinic

Tbilisi, Georgia

Outcomes

Primary Outcomes

12-ecg and echocardiography evaluation after 1 month treatment

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.